Skip to main content
. 2022 Sep 21;22(5):e37. doi: 10.4110/in.2022.22.e37

Figure 1. CAR and CAAR T cell therapies in clinical development for autoimmune diseases (ClinicalTrials.gov).

Figure 1

*Clinical development for multiple myeloma and plasmacytoid lymphoma.